RadioPharm Theranostics

About:

RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

Website: https://www.radiopharmtheranostics.com

Twitter/X: TeamRadioPharm

Top Investors: Lantheus Holdings, Radium Capital

Description:

RadioPharm Theranostics develops radiopharmaceutical products for diagnostic and therapeutic uses. They apply the potential of radiopharmaceuticals in treating oncological diseases. Their radiopharmaceuticals are safe radioactive drugs for use as diagnostic and therapeutic tools.

Total Funding Amount:

9.4M AUD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Carlton South, Victoria, Australia

Founded Date:

2021-01-01

Contact Email:

info(AT)radiopharmaceuticals.com

Founders:

Paul Hopper

Number of Employees:

11-50

Last Funding Date:

2024-06-20

IPO Status:

Public

Industries: